共 40 条
An indolent B-cell lymphoma with t(2;8)(p12;q24) abnormality and absence of C-MYC amplification and TP53 deletion.: A new variant?
被引:2
|作者:
Potti, A
Panwalkar, A
Ingebretson, MC
Tharapel, SA
Goodell, M
Dayton, MV
Mehdi, SA
机构:
[1] Univ N Dakota, Sch Med, Vet Affairs Med Ctr, Div Hematol Oncol, Fargo, ND 58102 USA
[2] Univ N Dakota, Sch Med, Dept Med, Fargo, ND USA
[3] Vet Affairs Med Ctr, Dept Pathol, Cytogenet Reference Lab, Memphis, TN USA
[4] Univ Minnesota, Dept Hematopathol, Minneapolis, MN USA
关键词:
D O I:
10.1016/S0165-4608(02)00931-7
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
The translocation between chromosomes 2 and 8, t(2;8), is well known for its strong association with high-grade Burkitt lymphoma. However, the significance of this translocation in indolent lymphoproliferative disorders is not clear. We present the case of a 75-year-old white male with left upper quadrant abdominal pain, splenomegaly, and an elevated white cell count of 30.3 x 10(9) cells/L (84% large lymphoid cells with scanty cytoplasm and prominent central nucleoli). Immunophenotyping revealed a clonal B-cell population coexpressing CD5, CD19, and CD20 with weak CD23 and CD25 and very weak, restricted, surface lambda. The cytogenetic analysis showed all 20 cells with t(2;8)(p12;q24.3). In addition, four of the 20 cells also showed a second translocation: t(12;17)(p13;q21). Molecular analysis using c-myc and p53 probes showed normal results with no indication of amplification of C-MYC or deletion of TP53. The patient was managed as an indolent/low-grade lymphoproliferative disorder with excellent response to eight cycles of fludarabine. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:76 / 79
页数:4
相关论文